The Index
400 dossiers · 1 need attention
A research screener for every company we cover. Search a name or ticker, then sort and triage dossiers by coverage freshness, our conviction and trading relevance.
No call10 names· avg TR 4 | ||||||||
| ALB is a high-quality, low-cost lithium asset wearing the price tag of a leveraged call option on the lithium spot price — own the resources, not the P&L; the stock is the commodity in a cyclical costume. | — | 0 | ||||||
| The world's lowest-cost EV/battery manufacturer is now margin-bleeding in a brutal domestic price war it helped start; the entire bull case has migrated to a high-margin export ramp that tariffs and a Brazil/Hungary regulatory cloud are built to throttle — cheap on forward P/E only if you trust earnings that GMT says are flattered by ~¥300B of supply-chain-financed hidden debt. | — | 0 | ||||||
| The cheapest dominant company in the world — a 40%-share, 27%-ROE compounder priced at ~22x because it carries a Chinese-passport discount and a US-blacklist overhang the market refuses to underwrite away; bullish, but the re-rate needs a geopolitical thaw that may never come. | — | 0 | ||||||
| A levered call option on US grid-storage demand and IRA/OBBBA domestic-content rules — record $5.6B backlog and two hyperscaler deals validate the funnel, but 7–13% gross margins, a 50%-H2-weighted year, and a stock above the average analyst target leave it priced for flawless execution it has repeatedly failed to deliver. | — | 0 | ||||||
| The cheapest electron-storage on the grid at the worst round-trip efficiency on the grid — a genuine multi-day monopoly whose moat (iron at $0.10/kWh, a US steel-mill factory, ArcelorMittal upstream) is only worth owning if regulators keep paying for firm capacity rather than cheap throughput; the Google $1B deal proves demand exists, the sub-40% RTE proves the bet is on policy and capacity value, not arbitrage. | — | 0 | ||||||
| A great battery operator strapped to a collapsing demand curve and a U.S. subsidy that is its only profit — the franchise is real, but the 2027-2032 order book just lost ~$9B of contracted Ford/FBPS volume and AMPC repeal is an existential tail risk; WATCHING, not buying, until the ESS pivot proves it can replace lost auto cells at a real margin. | — | 8 | ||||||
| A premium-cell incumbent being squeezed from below by Chinese LFP scale and above by its own Tesla over-concentration — but the unit now has a genuine second engine (data-center backup, ~80% share) that the parent's 46x-PER stock does not yet price as a battery turnaround. | — | 8 | ||||||
| A genuine ceramic-separator moat wrapped around a capital-light VW/PowerCo license — but the equity is a $4.4B option on a $130M royalty cheque that has NOT yet been triggered, burning ~$60M/quarter of cash against a binary milestone it does not control. | — | 8 | ||||||
| A loss-making #9 EV-cell laggard re-rating on an ESS/data-center pivot the market is pricing as a turnaround — the call is whether US grid-storage demand and 2027 solid-state outrun Chinese LFP deflation before the balance sheet (rights issue + Display-stake sale) runs out of runway. | — | 8 | ||||||
| A structurally sub-scale #6 battery maker whose survival now rests on a US-policy bet that just inverted — the Ford anchor is gone, EV demand cratered, and the entire growth pivot (ESS/LFP) is a margin-thin race into China's home turf; only the SK Group balance sheet keeps it solvent, and there is no tradeable security to express a view on. | — | 8 | ||||||